Document is current
Any future updates will be listed below
-
Authors
Zheng, Mei-Mei https://orcid.org/0000-0002-3493-7139
Zhou, Qing https://orcid.org/0000-0002-0478-176X
Chen, Hua-Jun
Jiang, Ben-Yuan
Tang, Li-Bo https://orcid.org/0000-0002-4870-4408
Jie, Guang-Ling
Tu, Hai-Yan
Yin, Kai
Sun, Hao
Liu, Si-Yang https://orcid.org/0000-0002-5105-6421
Zhang, Jia-Tao https://orcid.org/0000-0003-4302-9332
Xiao, Fa-Man
Yang, Jin-Ji
Zhang, Xu-Chao https://orcid.org/0000-0002-4138-8115
Zhong, Wen-Zhao
Pan, Yi https://orcid.org/0000-0003-4945-5631
Wang, Bin-Chao
Yan, Hong-Hong
Guo, Wei-Bang
Chen, Zhi-Hong
Wang, Zhen
Xu, Chong-Rui
Li, Su-Yun
Liu, Si-Yang Maggie
Zeng, Lu
Cai, Shang-Li https://orcid.org/0000-0002-5063-5712
Wang, Guo-Qiang
Zhu, Dong-Qin
Li, Yang-Si https://orcid.org/0009-0008-1372-4418
Wu, Yi-Long https://orcid.org/0000-0002-3611-0258
- License Information
-
More Information
Article History
Received: 17 November 2023
Accepted: 27 January 2025
First Online: 27 February 2025
Competing interests
: Q.Z. declares honoraria from AstraZeneca, Boehringer Ingelheim, BMS, Eli Lilly, MSD, Pfizer, Roche and Sanofi outside the submitted work. W.Z.Z. declares honoraria from AstraZeneca, BMS, MSD, Roche and Innovent outside the submitted work. Y.L.W. declares: advisory services for AstraZeneca, Boehringer Ingelheim, Novartis and Takeda; speaker fees from AstraZeneca, Beigene, Boehringer Ingelheim, BMS, Eli Lilly, MSD, Pfizer, Roche and Sanofi; and grants from AstraZeneca, Boehringer Ingelheim, BMS, Hengrui and Roche outside the submitted work. The remaining authors declare no competing interests.
